KFG
PFE icon

Kingdom Financial Group’s Pfizer PFE Stock Holding History

Kingdom Financial Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.1K Sell
587
-84
-13% -$2.2K ﹤0.01% 425
2026
Q1 		$18.8K Buy
671
+91
+16% +$2.42K 0.01% 397
2025
Q4 		$14.4K Buy
+580
New +$14.6K ﹤0.01% 383

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Kingdom Financial Group's PFE Position: Q2 2026 in Review

Kingdom Financial Group reduced its Pfizer (PFE) stake by 13% in Q2 2026, selling an estimated $2.2K and leaving 587 shares worth $14.1K. The position accounts for ﹤0.01% of the portfolio, ranked #425.

Kingdom Financial Group first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $18.8K in Q1 2026. 2,829 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Kingdom Financial Group held 587 shares of Pfizer worth $14.1K as of Q2 2026.
  • Kingdom Financial Group sold 84 Pfizer shares in Q2 2026, an estimated $2.2K.
  • Pfizer made up ﹤0.01% of Kingdom Financial Group's portfolio in Q2 2026, its #425 holding.
  • Kingdom Financial Group first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • Kingdom Financial Group's Pfizer position peaked at $18.8K in Q1 2026.
  • 2,829 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Kingdom Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.